Sign in Subscribe
Share

The GenAI Divide: Beyond the 95% Failure Myth and the Workslop Epidemic

MIT revealed 95% of enterprises gain no ROI from GenAI—a headline that fuels skepticism but masks the deeper truth: the GenAI Divide. A small 5% capture massive value, while most drown in stalled pilots and workslop. Success hinges not on hype, but on governance and strategy.

The GenAI Divide: Beyond the 95% Failure Myth and the Workslop Epidemic

This post is for paying subscribers only

Already have an account? Sign in.

Subscribe to The Strategy Brief

Sign up now to get access to the library of members-only issues.
jamie@example.com
Subscribe